{
  "Disease": [
    {"role": "user", "content": "Please identify the \"Disease\" entities in the following paragraph. Please present the valid entities as a Markdown table with one column \"Disease\". Make sure to present the entities precisely in the same words as in the original paragraph.\n\nParagraph: Indications for transplantation were idiopathic cardiomyopathy ( 52 % ) , congenital heart disease ( 35 % ) with and without prior repair ( 71 % and 29 % , respectively ) , hypertrophic cardiomyopathy ( 5 % ) , valvular heart disease ( 3 % ) , and doxorubicin cardiomyopathy ( 5 % ) .\n\nLet's think step by step."},
    {"role": "assistant", "content": "| Disease |\n| --- |\n| idiopathic cardiomyopathy |\n| congenital heart disease |\n| hypertrophic cardiomyopathy |\n| doxorubicin cardiomyopathy |\n| valvular heart disease |"},
    {"role": "user", "content": "Please remove entities that do not clearly refer to \"Disease\" and present the valid entities as a Markdown table with one column \"Disease\".\n\nMake sure to present the entities precisely in the same words as in the original paragraph."},
    {"role": "assistant", "content": "| Disease |\n| --- |\n| idiopathic cardiomyopathy |\n| congenital heart disease |\n| hypertrophic cardiomyopathy |\n| doxorubicin cardiomyopathy |\n| valvular heart disease |\n\nThe entity \"congenital heart disease\" is included as it is a general category of heart conditions present from birth, and specific types of congenital heart diseases are mentioned later in the paragraph."}
  ],
  "Chemical": [
    {"role": "user", "content": "Please identify the \"Chemical\" entities in the following paragraph. Please present the valid entities as a Markdown table with one column \"Chemical\". Make sure to present the entities precisely in the same words as in the original paragraph.\n\nParagraph: Indications for transplantation were idiopathic cardiomyopathy ( 52 % ) , congenital heart disease ( 35 % ) with and without prior repair ( 71 % and 29 % , respectively ) , hypertrophic cardiomyopathy ( 5 % ) , valvular heart disease ( 3 % ) , and doxorubicin cardiomyopathy ( 5 % ) .\n\nLet's think step by step."},
    {"role": "assistant", "content": "| Chemical |\n| --- |\n| doxorubicin |\n\nExplanation:\n\nThe paragraph mentions one chemical entity, \"doxorubicin,\" which is a type of chemotherapy drug known to cause heart problems, specifically doxorubicin cardiomyopathy."},
    {"role": "user", "content": "Please remove entities that do not clearly refer to \"Chemical\" and present the valid entities as a Markdown table with one column \"Chemical\".\n\nMake sure to present the entities precisely in the same words as in the original paragraph."},
    {"role": "assistant", "content": "| Chemical |\n| --- |\n| doxorubicin |\n\nExplanation:\n\nThe revised paragraph still only mentions one chemical entity, \"doxorubicin,\" which is a type of chemotherapy drug known to cause heart problems, specifically doxorubicin cardiomyopathy. None of the other conditions mentioned in the paragraph are chemical entities."}
  ]
}